Dr. Shashi Bala Singh a Distinguished Scientist and Director General , Life Sciences (DG LS) in Defence Research and Development Organisation till 1st June 2018. Prior to DGLS she was ‘H’/Outstanding Scientist and Director of Defence Institute of Physiology and Allied Sciences (DIPAS), Delhi since 2010. A person with strong will, she has the distinction of serving as the Director of Defence Institute of High Altitude Research (DIHAR), Leh, from 2007 to 2010. She is an alumini of All India Institute of Medical Sciences (AIIMS) where she obtained her Ph.D. degree in Human Physiology in 1986 and started her career in DRDO at DIPAS, Delhi in 1990. She was awarded D.Sc. from Bharathiar University in 2014.Full Profile
Dr.Nanduri Received PhD in Organic Chemistry from Sri Sathya Sai Institute of Higher Learning, Prasanthinilayam, A.P. India in the year 1991 and continued as a faculty for three years. Moved on to the R & D centre of Dr Reddy’s Laboratories in the year 1995 and spent close to 13 years in various positions of increasing responsibilities. Led and managed various drug discovery programmes of Dr Reddy’s Laboratories in the areas of oncology and metabolic disorders as Senior Director, Medicinal Chemistry. Subsequently, joined Biocon BMS Research Centre, Bangalore, as Chief Scientific Manager. Later on moved to Aurigene Discovery Technologies Ltd., (a subsidiary of Dr Reddy’s Laboratories) as Research Director, Medicinal Chemistry in 2008. Led a number of integrated drug discovery programmes in the area of Oncology in collaboration with various pharmaceutical companies. His recent industrial assignment has been with Albany Molecular Research (AMRI), Hyderabad Research Centre as Director, Medicinal Chemistry.Full Profile
Dr. Saurabh Srivastava has pursued his Masters in Pharmaceutical Sciences from “Birla Institute of Technology and Science (BITS), Pilani, Rajasthan and Ph.D. from “Panjab University, Chandigarh”. He carries profound industrial and research experience working with several Pharmaceutical R&Ds, including IPCA labs, Mumbai, Wockhardt research centre, Aurangabad and Dr. Reddy’s Laboratories, Hyderabad for development and commercialization of various NDA and ANDA based products for different regulated markets. His area of research interests are development and optimization of Industrially viable, feasible and scalable “Differentiated formulations” (505(b)2, through utilization of “Micro/Nanostructured” Targeted drug deliveries along with Novel platform technologies, including “Amorphous solid dispersion”, “Fluidized bed processing”, “Particle coating” (Wurster process), “Pellet based controlled drug deliveries” “Compression coating”, Multiple Unit Particulate Systems (MUPS), “Osmotic drug deliveries” and “Lipid based drug carriers” for the purpose of “Bioavailability enhancement”, “Food effect minimization”, “Repurposing/New Indication”, “Synergism for FDCs”, “Dose/Dosing frequency reduction”. His major therapeutic area of research is “Neurodegenerative disorders”, “Dermal diseases”, “GI disorders” and “Chronotherapeutics”. He has 02 “Commercial Products”, 08 “International and National Patents” and several research publications in Journals of International and National repute with 250+ citations to his credit.